Table of Content

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15

2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 26
2.4 Emerging Opportunities and Market Trends 29
2.5 Porter’s Fiver Forces Analysis 33

3 Segmentation of Asia Pacific Market by Treatment Type 37
3.1 Market Overview by Treatment Type 37
3.2 Medication 39
3.3 Stem Cell Therapy 41
3.4 Other Treatments 42

4 Segmentation of Asia Pacific Market by ALS Type 43
4.1 Market Overview by ALS Type 43
4.2 Sporadic ALS 45
4.3 Familial ALS 46

5 Segmentation of Asia Pacific Market by Distribution Channel 47
5.1 Market Overview by Distribution Channel 47
5.2 Hospital Pharmacies 49
5.3 Retail Pharmacies 50
5.4 Online Pharmacies 51
5.5 Other Distribution Channels 52

6 Asia-Pacific Market 2020-2027 by Country 53
6.1 Overview of Asia-Pacific Market 53
6.2 China 56
6.3 Japan 58
6.4 India 61
6.5 Australia 63
6.6 South Korea 65
6.7 Rest of APAC Region 67

7 Competitive Landscape 69
7.1 Overview of Key Vendors 69
7.2 New Product Launch, Partnership, Investment, and M&A 72
7.3 Company Profiles 73
AB Science SA 73
Amylyx Pharmaceuticals Inc. 75
Biogen Inc. 76
Biohaven Pharmaceutical Holding Co., Ltd. 77
BrainStorm Cell Limited 78
Corestem, Inc. 79
F.Hoffmann-La Roche AG 80
Ionis Pharmaceuticals, Inc. 81
Mitsubishi Tanabe Pharma Corporation 82
Otsuka Pharmaceutical Co., Ltd. 83
Sun Pharmaceutical Industries Ltd. 84
RELATED REPORTS 85



List of Figures

Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 15
Figure 4. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market 22
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 25
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market 26
Figure 9. Investment Opportunity Analysis 30
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market 33
Figure 11. Breakdown of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2020-2027, % of Revenue 37
Figure 12. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Treatment Type, Value ($ mn) and Share (%) 38
Figure 13. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication, 2017-2027, $ mn 39
Figure 14. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Stem Cell Therapy, 2017-2027, $ mn 41
Figure 15. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Treatments, 2017-2027, $ mn 42
Figure 16. Breakdown of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2020-2027, % of Revenue 43
Figure 17. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by ALS Type, Value ($ mn) and Share (%) 44
Figure 18. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Sporadic ALS, 2017-2027, $ mn 45
Figure 19. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Familial ALS, 2017-2027, $ mn 46
Figure 20. Breakdown of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2020-2027, % of Revenue 48
Figure 21. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 48
Figure 22. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Hospital Pharmacies, 2017-2027, $ mn 49
Figure 23. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Retail Pharmacies, 2017-2027, $ mn 50
Figure 24. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Online Pharmacies, 2017-2027, $ mn 51
Figure 25. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Distribution Channels, 2017-2027, $ mn 52
Figure 26. Breakdown of APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 54
Figure 27. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 55
Figure 28. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in China, 2017-2027, $ mn 56
Figure 29. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Japan, 2017-2027, $ mn 59
Figure 30. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in India, 2017-2027, $ mn 61
Figure 31. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Australia, 2017-2027, $ mn 63
Figure 32. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in South Korea, 2017-2027, $ mn 65
Figure 33. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of APAC, 2017-2027, $ mn 67
Figure 34. Growth Stage of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Industry over the Forecast Period 69

List of Tables

Table 1. Snapshot of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Balanced Perspective, 2020-2027 16
Table 2. Growth Rate of World GDP, 2020-2022 19
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market 29
Table 4. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 37
Table 5. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication by Type, 2017-2027, $ mn 40
Table 6. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 43
Table 7. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 47
Table 8. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, $ mn 54
Table 9. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 57
Table 10. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 57
Table 11. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 57
Table 12. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 60
Table 13. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 60
Table 14. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 60
Table 15. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 62
Table 16. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 62
Table 17. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 62
Table 18. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 64
Table 19. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 64
Table 20. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 64
Table 21. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 66
Table 22. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 66
Table 23. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 66
Table 24. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of APAC by Country/Region, 2017-2027, $ mn 68
Table 25. AB Science SA: Company Snapshot 73
Table 26. AB Science SA: Business Segmentation 73
Table 27. AB Science SA: Product Portfolio 74
Table 28. AB Science SA: Revenue, 2017-2019, $ mn 74